» Articles » PMID: 36324672

Processed Lateral Root of Debx.: A Review of Cardiotonic Effects and Cardiotoxicity on Molecular Mechanisms

Overview
Journal Front Pharmacol
Date 2022 Nov 3
PMID 36324672
Authors
Affiliations
Soon will be listed here.
Abstract

Fuzi, the lateral root of Debx., is a typical traditional herbal medicine with both poisonousness and effectiveness, and often used in the treatment of heart failure and other heart diseases. In this review, we searched domestic and foreign literature to sort out the molecular mechanisms of cardiotonic and cardiotoxicity of Fuzi, also including its components. The major bioactive components of Fuzi for cardiotonic are total alkaloids, polysaccharide and the water-soluble alkaloids, with specific mechanisms manifested in the inhibition of myocardial fibrosis, apoptosis and autophagy, and improvement of mitochondrial energy metabolism, which involves RAAS system, PI3K/AKT, JAK/STAT, AMPK/mTOR signaling pathway, etc. Diester-diterpenoid alkaloids in Fuzi can produce cardiotoxic effects by over-activating Na and Ca ion channels, over-activating NLRP3/ASC/caspase-3 inflammatory pathway and mitochondria mediated apoptosis pathway. And three clinically used preparations containing Fuzi are also used as representatives to summarize their cardiac-strengthening molecular mechanisms. To sum up, Fuzi has shown valuable cardiotonic effects due to extensive basic and clinical studies, but its cardiotonic mechanisms have not been systematically sorted out. Therefore, it is a need for deeper investigation in the mechanisms of water-soluble alkaloids with low content but obvious therapeutic effect, as well as polysaccharide.

Citing Articles

Cardiovascular protection of YiyiFuzi powder and the potential mechanisms through modulating mitochondria-endoplasmic reticulum interactions.

Ding J, Ji R, Wang Z, Jia Y, Meng T, Song X Front Pharmacol. 2024; 15:1405545.

PMID: 38978978 PMC: 11228702. DOI: 10.3389/fphar.2024.1405545.


The modern scientific mystery of traditional Chinese medicine processing--take some common traditional Chinese medicine as examples.

Tian Y, Shi Y, Zhu Y, Li H, Shen J, Gao X Heliyon. 2024; 10(2):e25091.

PMID: 38312540 PMC: 10835376. DOI: 10.1016/j.heliyon.2024.e25091.


Pharmacological effects and mechanisms of YiYiFuZi powder in chronic heart disease revealed by metabolomics and network pharmacology.

Wang Y, Li X, Qi M, Li X, Zhang F, Wang Y Front Mol Biosci. 2023; 10:1203208.

PMID: 37426419 PMC: 10327484. DOI: 10.3389/fmolb.2023.1203208.


Synthesis, Pharmacological Evaluation, and Molecular Modeling of Lappaconitine-1,5-Benzodiazepine Hybrids.

Cheremnykh K, Bryzgalov A, Baev D, Borisov S, Sotnikova Y, Savelyev V Molecules. 2023; 28(10).

PMID: 37241973 PMC: 10223824. DOI: 10.3390/molecules28104234.

References
1.
van Eldik W, Passier R . Signalling in sarcomeres in development and disease. Neth Heart J. 2013; 21(7-8):367-71. PMC: 3722383. DOI: 10.1007/s12471-013-0435-6. View

2.
Tai C, El-Shazly M, Tsai Y, Csupor D, Hohmann J, Wu Y . Uncovering Modern Clinical Applications of Fuzi and Fuzi-Based Formulas: A Nationwide Descriptive Study With Market Basket Analysis. Front Pharmacol. 2021; 12:641530. PMC: 8110898. DOI: 10.3389/fphar.2021.641530. View

3.
Tingting H, Guangzhong L, Yanxiang Z, DongDong Y, Li S, Li W . Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits. Naunyn Schmiedebergs Arch Pharmacol. 2019; 392(5):585-592. DOI: 10.1007/s00210-018-01611-0. View

4.
Xu P, Zhang W, Xie J, Wen Y, Zhang G, Lu S . Shenfu injection prevents sepsis-induced myocardial injury by inhibiting mitochondrial apoptosis. J Ethnopharmacol. 2020; 261:113068. DOI: 10.1016/j.jep.2020.113068. View

5.
Jiang B, Lin S, Zhu C, Wang S, Wang Y, Chen M . Diterpenoid alkaloids from the lateral root of Aconitum carmichaelii. J Nat Prod. 2012; 75(6):1145-59. DOI: 10.1021/np300225t. View